Cargando…

Gender differences and outcome of melanoma patients

Detalles Bibliográficos
Autores principales:	Morgese, Francesca, Berardi, Rossana, Sampaolesi, Caterina, Torniai, Mariangela, Marcantognini, Giulia, Giacchetti, Alfredo, Serresi, Stefano, Onofri, Azzurra, Bittoni, Alessandro, Pilone, Alberta, Ricotti, Giuseppe, Cascinu, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315278/ http://dx.doi.org/10.1186/1479-5876-13-S1-P13

Ejemplares similares

Gender Differences and Outcomes in Melanoma Patients
por: Morgese, Francesca, et al.
Publicado: (2020)

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex
por: Berardi, Rossana, et al.
Publicado: (2016)

Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients
por: Morgese, Francesca, et al.
Publicado: (2017)

Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials
por: Berardi, Rossana, et al.
Publicado: (2016)

The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions
por: Berardi, Rossana, et al.
Publicado: (2020)

Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study
por: Berardi, Rossana, et al.
Publicado: (2020)

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
por: Berardi, Rossana, et al.
Publicado: (2010)

Benefits and Limitations of a Multidisciplinary Approach in Cancer Patient Management
por: Berardi, Rossana, et al.
Publicado: (2020)

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management
por: Mentrasti, Giulia, et al.
Publicado: (2020)

Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy
por: Berardi, Rossana, et al.
Publicado: (2015)

Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
por: Berardi, Rossana, et al.
Publicado: (2016)

Role of maspin in cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer
por: Berardi, Rossana, et al.
Publicado: (2013)

Systemic treatment for lung carcinoids: from bench to bedside
por: Torniai, Mariangela, et al.
Publicado: (2019)

Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows
por: Torniai, Mariangela, et al.
Publicado: (2022)

The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer
por: Berardi, Rossana, et al.
Publicado: (2020)

[(11)C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas
por: Santoni, Matteo, et al.
Publicado: (2014)

Somatostatin analogs: is one better than other?
por: Rossana, Berardi, et al.
Publicado: (2017)

Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy
por: Giampieri, Riccardo, et al.
Publicado: (2019)

A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy
por: Torresetti, Matteo, et al.
Publicado: (2020)

Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy
por: Bittoni, Alessandro, et al.
Publicado: (2014)

Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic
por: Ballatore, Zelmira, et al.
Publicado: (2020)

High CTLA-4 expression correlates with poor prognosis in thymoma patients
por: Santoni, Giorgio, et al.
Publicado: (2018)

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
por: Conti, Alessandro, et al.
Publicado: (2013)

Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review
por: De Lisa, Mariagrazia, et al.
Publicado: (2020)

Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis
por: Lenci, Edoardo, et al.
Publicado: (2021)

Primum non Nocere: How to ensure continuity of care and prevent cancer patients from being overlooked during the COVID‐ 19 pandemic
por: Agostinelli, Veronica, et al.
Publicado: (2022)

Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis
por: Bittoni, Alessandro, et al.
Publicado: (2015)

Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review
por: Cognigni, Valeria, et al.
Publicado: (2021)

Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms
por: Berardi, Rossana, et al.
Publicado: (2018)

Optimal management of resected gastric cancer
por: Giampieri, Riccardo, et al.
Publicado: (2018)

Seminoma Retroperitoneal Relapse 23 Years After Surgery
por: Crocetti, Sonia, et al.
Publicado: (2021)

The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib
por: Faloppi, Luca, et al.
Publicado: (2015)

P1109: EPIDEMIOLOGY OF CUTANEOUS T-CELL LYMPHOMAS: DATA ANALYSIS FROM THE MARCHE MULTIDISCIPLINARY TEAM (MDT) REGISTER.
por: Morsia, Erika, et al.
Publicado: (2023)

Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer
por: Pecci, Federica, et al.
Publicado: (2021)

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management
por: Del Prete, Michela, et al.
Publicado: (2015)

Bone Metabolism in SARS-CoV-2 Disease: Possible Osteoimmunology and Gender Implications
por: Salvio, Gianmaria, et al.
Publicado: (2020)

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New
por: Faloppi, Luca, et al.
Publicado: (2016)

Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach
por: Bittoni, Alessandro, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mf0dvbcbdgoig236v8rub8njne